Fundraising FoxGPB Scientific, Inc.
Richmond, US · 2 known investors
Find your way into GPB Scientific, Inc.
Sign up to see every warm intro you have to GPB Scientific, Inc.
- Paths you didn't know you had: your email and LinkedIn already hold routes to the GPB Scientific, Inc. team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
Founders & leadership
Investors · 2
Amgen VenturesreportedThousand Oaks · $1M – $3M
How we know: prnewswire.com · press coverage · Not right? Tell us
Vensana CapitalreportedMinneapolis
How we know: a partner's Signal profile · prnewswire.com · press coverage · Not right? Tell us
Reported raises · per SEC filings
Form D private placements$42.3M disclosed across 9 rounds · 2013–2022
▶$3.6MraisedSep 2022 · 40 investors · BiotechnologyRule 506(b)
▶$3.6MraisedSep 2022 · 40 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $10M
- Amount sold
- $3.6M
- First sale
- Jul 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$17MraisedApr 2021 · 39 investors · BiotechnologyRule 506(b)
▶$17MraisedApr 2021 · 39 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $18M
- Amount sold
- $17M
- First sale
- Apr 2021
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$15.5MraisedMar 2020 · 2 investors · BiotechnologyRule 506(b)
▶$15.5MraisedMar 2020 · 2 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $25M
- Amount sold
- $15.5M
- First sale
- Mar 2020
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.5MraisedSep 2019 · 23 investors · BiotechnologyRule 506(b)
▶$1.5MraisedSep 2019 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $1.5M
- Amount sold
- $1.5M
- Sales commissions
- $200K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- May 2019
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$500KraisedJun 2018 · 1 investors · BiotechnologyRule 506(b)
▶$500KraisedJun 2018 · 1 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $10M
- Amount sold
- $500K
- Sales commissions
- $104.1K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- May 2018
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$810KraisedFeb 2017 · 21 investors · BiotechnologyRule 506(b)
▶$810KraisedFeb 2017 · 21 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $2.5M
- Amount sold
- $810K
- Sales commissions
- $8.4K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- Feb 2017
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$1.4MraisedJan 2016 · 12 investors · BiotechnologyRule 506(b)
▶$1.4MraisedJan 2016 · 12 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $3M
- Amount sold
- $1.4M
- Sales commissions
- $87K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- Jan 2016
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
▶$110KraisedJul 2015 · 6 investors · BiotechnologyRule 506(b)
▶$110KraisedJul 2015 · 6 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- Michael D. GrishamExecutive Officer
- Offering amount
- $2M
- Amount sold
- $110K
- Sales commissions
- $7.7K
- Placement agents
- Walter Greenblatt & Associates, LLC
- First sale
- Jul 2015
- Incorporated
- Limited Liability Company, Delaware
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 6 SBIR/STTR awards
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Institutes of Health (NIH)National Institutes of Health | Phase II | 2022 | $250K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2019 | $1.8M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2018 | $280K |
| National Institutes of Health (NIH)National Institutes of Health | Phase IISTTR | 2015 | $1.4M |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $245K |
| National Institutes of Health (NIH)National Institutes of Health | Phase ISTTR | 2012 | $241.3K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
In the news
Frequently asked questions
- Who are GPB Scientific, Inc.'s investors?
- GPB Scientific, Inc.'s investors include Amgen Ventures, Vensana Capital.
- How much funding has GPB Scientific, Inc. raised?
- GPB Scientific, Inc. has disclosed $42.3M raised across 9 rounds.
- Where is GPB Scientific, Inc. headquartered?
- GPB Scientific, Inc. is headquartered in Richmond, US.